Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

Published Date: 30 Aug 2023

According to recent studies presented in a Hot Line session, twelve months of edoxaban is superior to three months for reducing thrombotic events in patients with cancer and distal deep vein thrombosis (DVT).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Smart exercise planning could boost recovery for people with cancer

2.

Top FDA Official Exits; SCOTUS Takes Up Obamacare Case; Texas Doc Suspended

3.

PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.

4.

Sub-Q Ketamine is Safe and Very Effective for Severe Depression.

5.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot